LIA
ABBV icon

LifePlan Investment Advisors’s AbbVie ABBV Stock Holding History

LifePlan Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$642K Sell
2,950
-271
-8% -$60.1K 0.25% 81
2025
Q4 		$736K Buy
3,221
+248
+8% +$56.5K 0.3% 70
2025
Q3 		$688K Buy
2,973
+336
+13% +$68.4K 0.29% 69
2025
Q2 		$489K Buy
2,637
+4
+0.2% +$743 0.24% 71
2025
Q1 		$552K Buy
+2,633
New +$512K 0.32% 67

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LifePlan Investment Advisors's ABBV Position: Q1 2026 in Review

LifePlan Investment Advisors reduced its AbbVie (ABBV) stake by 8.4% in Q1 2026, selling an estimated $60.1K and leaving 2,950 shares worth $642K. The position accounts for 0.25% of the portfolio, ranked #81.

LifePlan Investment Advisors first reported a position in ABBV in Q1 2025 and has held it in 5 quarters since. The position peaked at $736K in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • LifePlan Investment Advisors held 2,950 shares of AbbVie worth $642K as of Q1 2026.
  • LifePlan Investment Advisors sold 271 AbbVie shares in Q1 2026, an estimated $60.1K.
  • AbbVie made up 0.25% of LifePlan Investment Advisors's portfolio in Q1 2026, its #81 holding.
  • LifePlan Investment Advisors first reported a position in AbbVie in Q1 2025 and has held it in 5 quarters since.
  • LifePlan Investment Advisors's AbbVie position peaked at $736K in Q4 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on LifePlan Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.